The city of Sacramento, California, currently has 3 active clinical trials seeking participants for Type 2 Diabetes research studies.
A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Recruiting
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
06/03/2025
Locations: UC Davis Medical Group GI Unit, Sacramento, California
Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases
Use of CGM in Kidney Transplant Recipients
Recruiting
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/29/2025
Locations: UC Davis Health, Sacramento, California
Conditions: Kidney Transplant; Complications, Diabetes Mellitus, Type 2, Insulin Dependent Diabetes
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
Recruiting
This is a Phase IIb, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes mellitus, compared to placebo and active comparator.
Gender:
ALL
Ages:
All
Trial Updated:
04/25/2025
Locations: Research Site, Sacramento, California
Conditions: Diabetes Mellitus, Type 2